Clinical value of glycated hemoglobin and fructosamine in the long-term glycemic control of children with acute lymphoblastic leukemia

Pediatrics International

Volumn 40, Issue 1, 1998, Pages 52-56

  Yetgin, Sevgi ^a   Yalcln, S Songul ^a   Ozbek, Nam Ik ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Fructosamine. glycated hemoglobin; Hyperglycemia

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; FEMALE; FRUCTOSAMINE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHYLPREDNISOLONE; PREDNISOLONE; RISK FACTORS;

EID: 0031886394     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01402.x     Document Type: Article

References (16)

1. Çetin M, Yetgin S, Kara A et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J. Med. 1994; 25: 219–29.
2. Dacou-Voutetakis C, Palis J, Haidas S, Zannos-Mariolea L, Georgiopoulou P, Matsaniotis N. Abnormal glucose tolerance in children with acute leukemia: Effect of induction chemotherapy including L-asparaginase. Am. J. Pediatr. Hematol. Oncol. 1983; 5: 139–46.
3. Gailani S, Nussbaum A, Ohnuma T, Freeman A. Diabetes in patients treated with asparaginase. Clin. Pharmacol. Then 1971;12: 487–90.
4. Land VJ, Sutow WW, Fernbach DJ, Lane DM, Williams TE. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972; 30: 339–47.
5. Ortega JA Nesbit ME Jr, Donaldson MH et al. L-Asparaginase. vincristine and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res. 1977; 37: 535–40.
6. Pastore G, Saracco P, Brach del Prever A, Iannacci L, Miniero R, Madon E. Glucose metabolism in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules. Acta Haematol. 1984; 72: 384–7.
7. Pui CH, Burghen GA, Bowman WP, Aur RJA. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J. Pediatr. 1981; 99: 46–50.
8. Turner GR, Marks JF, Buchanan GR. Relative hyper-glucagonemia in L-asparaginase- and prednisolone-induced glucose intolerance in management in acute lymphoblastic leukemia. Clin. Pedum: 1983:22: 363–7.
9. Lester E. The clinical value of glycated haemoglobin and glycated plasma proteins. Ann. Clin. Biochem. 1989: 26: 213–19.
10. Nathan DM. Singer DE. Hurxthal K. Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N. Engl. J. Med. 1984: 310: 341–6.
11. Alemzadeh R. Lifshitz F. Childhood obesity. In: Lifshitz F (eds). Pediatric Endocrinology. 3rd edn. Marcel Dekker Inc. New York. 1996: 753–74.
12. Rivera GK. Raimondi SC. Hancock ML et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991: 337: 61–6.
13. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerence. Diabetes 1979; 28: 1039–57.
14. Fairbanks VF. Zimmerman BR. Measurement of glycosylated hemoglobin by affinity chromatography. Mayo Clin. Proc. 1983: 58: 770–3.
15. Johnson RN. Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 1983; 127: 87–95.
16. Salemans TH, van Dieijen-Visser MR Brombacher PJ. The value of HbAl and fructosamine in predicting impaired glucose intolerance as an alternative to OGTT to detect diabetes mellitus or gestational diabetes. Ann. Clin. Biochem. 1987; 24: 447–52.